Prevalence and Causes of Blindness & Low Vision; Before and Five Years After ‘VISION 2020’ Initiatives in Oman: A Review

REFERENCES

• Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull WHO. 2004; 82(11)844–851
   PubMed Web of Science ®Google Scholar
• Khandekar R, Mohammed A J, Negrel A D, Riyami A A. The prevalence and causes of blindness in the Sultanate of Oman: The Oman Eye Study (OES). Br J Ophthalmol 2002; 86(9)957–962
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Sultanate of Oman. Blindness Survey Report; Oman Eye Study (OES). Mazoon Printing Press, Muscat, Oman 1998; 15–20
   Google Scholar
• World Health Organization, Cairo, Egypt 2003, http://whilibdoc.who.EMR/2003/WHOPBL/03.1pdf (WHO/EMR/PBL/03.1). Report on the conference on ‘VISION 2020. Planning for the Eastern Mediterranean Region’
   Google Scholar
• Ministry of Health, Sultanate of Oman. Eye Health Care Manual, 2nd ed. Al Zahra Printers, Muscat, Oman 2000; 6–7
   Google Scholar
• Ministry of National Economy, Sultanate of Oman. Census 2003. A monthly bulletin issued by the Administration of the 2003 census, 13th ed. Ministry of National Economy, Oman 2004; 20
   Google Scholar
• Ministry of Health, Sultanate of Oman. Annual Health Report for the year 2003. Al Zahra Printers, Muscat, Oman 2004; 1–4
   Google Scholar
• World Health Organization. World Health Report 2000. Health systems: Improving performance. WHO, Geneva 2000; 200
   Google Scholar
• World Health Organization. Prevention of Blindness & Deafness. Consultation on Development of Standards for Characterization of Vision loss & Visual Functioning. WHO, Geneva 2003; 9, (WHO/PBL/03.91)
   Google Scholar
• Courtright P, Hoechsmann A, Metcalfe N, et al. Changes in blindness prevalence over 16 years in Malawi: reduced prevalence but increased numbers of blind. Br J Ophthalmol 2003; 87(9)1079–1082
   PubMed Web of Science ®Google Scholar
• Khandekar R, Mohammed A. Cataract prevalence, cataract surgical coverage and its contribution to the reduction of visual disability in Oman. Ophthalmic Epidemiol 2004; 11(3)181–189
   PubMed Web of Science ®Google Scholar
• Lewallen S, Courtright P. Gender and use of cataract surgical services in developing countries. Bull WHO 2002; 80(4)300–303
   PubMed Web of Science ®Google Scholar
• Congdon N, O'Colmain B, Klaver C C, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122(4)477–485
   PubMed Web of Science ®Google Scholar
• Buch H, Vinding T, La Cour M, et al. Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology 2004; 111(1)53–61
   PubMed Web of Science ®Google Scholar
• Rothe Nissen K, Sjolie A K, Jensen H, et al. The prevalence and incidence of visual impairment in people of age 20-59 years in industrialized countries: a review. Ophthalmic Epidemiol 2003; 10(4)279–291
   PubMed Web of Science ®Google Scholar
• Chen J H, Xu L, Hu A L, et al. Prevalence of low vision and blindness in defined populations in rural and urban areas in Beijing. Zhonghua Yixue Zazhi 2003; 83(16)1413–1418
   Google Scholar
• Fotouhi A, Hashemi H, Mohammad K, Jalali K H. The prevalence and causes of visual impairment in Tehran: the Tehran Eye Study. Br J Ophthalmol 2004; 88(6)740–745
   PubMed Web of Science ®Google Scholar
• Dineen B P, Bourne R R, Ali S M, Huq D M, Johnson G J. Prevalence and causes of blindness and visual impairment in Bangladeshi adults: Results of the National Blindness and Low Vision Survey of Bangladesh. Br J Ophthalmol 2003; 87(7)820–828
   PubMed Web of Science ®Google Scholar
• Sulaiman Ali J M, Al Riyami A, Farid S M. Family Health Survey. 60–61, ISBN 9960-15-098-4
   Google Scholar
• Eye Health Care Program, Ministry of Health. Oman & Eye Health Care Manual, 1st Edition. UNICEF. 1995; 2–6
   Google Scholar
• Al-Lawati J A, Mohammed A J, Al-Hinai H Q, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003; 26(6)1781–1785
   PubMed Web of Science ®Google Scholar
• Rajab A, Patton M A. A study of consanguinity in the Sultanate of Oman. Ann Hum Biol. 2000; 27(3)321–326
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Sultanate of Oman. Annual Health Report for the year 2004. Al Zahra Printers, Muscat, Oman 2005; 8–48
   Google Scholar
• Kocure I. Vision 2020 and Disease control priorities and cataract. Implementation of VISION 2020 in the Eastern Mediterranean Region–Report on a regional planning workshop. World Health Organization. 2003, (WHO-EM/CPB/001/E)
   Google Scholar
• Khandekar R. Cataract Fortnight in Oman—A Report. Community Health & Disease Surveillance Newsletter 1998; 7(4)8, http://www.emro.who.info/CountryProfiles-oma-news.htm
   Google Scholar
• Thylefors B, Negrel A D, Parajasegaram R, Dadzie K Y. Global data on blindness. Bull WHO. 1995; 73(1)115–121
   PubMed Web of Science ®Google Scholar
• Khandekar R, Mohammed A J. Visual disabilities among diabetics in Oman. Saudi Med J. 2005; 26(5)836–841
   PubMed Web of Science ®Google Scholar
• Taylor H R. Cataract: How much surgery do we have to do?. Br J Ophthalmol 2000; 84: 1–2
   PubMed Web of Science ®Google Scholar
• Foster A, Resnikoff S. The impact of Vision 2020 on global blindness. Eye 2005; 19(10)1133–1135
   PubMed Web of Science ®Google Scholar